Clinical Trial Update: Painful HIV Neuropathy and Alpha-Lipoic Acid [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating alpha-lipoic acid for painful HIV-associated peripheral neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Peripheral Neuropathy

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV, Peripheral Neuropathy | Phase 1, Phase 2 | Status: COMPLETED